Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | mDC3/8-KRAS vaccine |
Synonyms | |
Therapy Description |
mDC3/8-KRAS vaccine is a cancer vaccine comprising patient-derived dendritic cells pulsed with patient-specific KRAS-mutant peptides, potentially resulting in increased anti-tumor immune response against KRAS-mutant tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
mDC3/8-KRAS vaccine | mDC3/8-KRAS vaccine is a cancer vaccine comprising patient-derived dendritic cells pulsed with patient-specific KRAS-mutant peptides, potentially resulting in increased anti-tumor immune response against KRAS-mutant tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03592888 | Phase I | mDC3/8-KRAS vaccine | DC Vaccine in Pancreatic Cancer | Completed | USA | 0 |